AI-driven platform that designs, builds, tests and learns from lipid nanoparticle formulations for targeted nucleic acid delivery.
Mana.bio's AI LNP Design Platform integrates machine learning with high-throughput nanotechnology to design novel lipid nanoparticle candidates in silico. The platform predicts desirable properties, selects tissue-targeted LNPs, and guides automated synthesis and screening. Experimental results feed back into the training set to improve models weekly.
The platform supports extrahepatic delivery of DNA- and RNA-based therapeutics and vaccines, aiming to overcome the liver limitation of current LNPs and unlock genetic medicines for a wider range of diseases.
Acuitas Therapeutics
LNP Delivery Technology
acuitastx.com
ReCode Therapeutics
SORT LNP Platform
recodetx.com
| Attribute | AI LNP Design Platform | LNP Delivery Technology | SORT LNP Platform | |
|---|---|---|---|---|
| Provider | | | | |
| Founded | 2021 | 2009 | 2015 | |
| Sells To | Enterprise | — | Enterprise, Small Business | |
| Pricing Model | Recurring, Software | — | Software | |
| Ownership | Venture-backed | — | Venture-backed |
Provider
Founded 2021
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Venture-backed
Provider
Founded 2009
Sells To —
Pricing Model —
Ownership —
Provider
Founded 2015
Sells To Enterprise, Small Business
Pricing Model Software
Ownership Venture-backed
Generate Platform is a generative biology platform that designs novel protein therapeutics.
An engineered transfer RNA platform that suppresses premature stop codons to restore protein translation.
STELLAR is Copernicus Therapeutics' non-viral gene delivery platform for compacted DNA nanoparticles.
Generate Platform is a generative biology platform that designs novel protein therapeutics.
An engineered transfer RNA platform that suppresses premature stop codons to restore protein translation.
STELLAR is Copernicus Therapeutics' non-viral gene delivery platform for compacted DNA nanoparticles.
